President Donald Trump signed an executive order aimed at ensuring a "resilient" supply chain for essential medicines in the U.S. by filling the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with critical drug components, the White House said on Wednesday.
The Office of the Assistant Secretary for Preparedness and Response within the Department of Health and Human Services is tasked with developing a list of about 26 critical drugs vital to "national health and security", the White House said in a fact sheet.
"The Order directs the Office ... and ready the SAPIR repository to receive and maintain the Active Pharmaceutical Ingredients (APIs) used to make these critical drugs."
CMAA enhances trade and security cooperation
View ArticleThe report highlights Africa’s continued growth resilience despite significant headwinds occasioned by escalating geopolitical tensions and ensuing economic shifts
View Article
As the UK marks ten years since the Brexit referendum, the British International Freight Association (BIFA) is highlighting the vital role played by its members in helping businesses adapt to…
View ArticleIndustry updates and weekly newsletter direct to your inbox!